Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 1:41 PM
Ignite Modification Date:
2025-12-25 @ 12:37 PM
NCT ID:
NCT03057795
Group ID:
EG000
Title:
Brentuximab Vedotin 1.8 mg/kg + Nivolumab 3 mg/kg Q21 Days
Description:
Beginning 30-60 days post-ASCT, patients receive brentuximab vedotin IV over 30 minutes and nivolumab IV over 60 minutes on day 1. Treatment repeats every 21 days for up to 8 cycles in the absence of disease progression or unacceptable toxicity.
Brentuximab Vedotin: Given IV Nivolumab: Given IV
Deaths Number Affected:
1
Deaths Number At Risk:
None
Serious Number Affected:
19
Serious Number At Risk:
59
Other Number Affected:
59
Other Number At Risk:
59
Study:
NCT03057795
Results Section:
NCT03057795
Adverse Events Module:
NCT03057795